The company has poor fundamentals for a short-term investment strategy.
The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at CAD 2.32 CAD in weekly data.
The close medium term support offers good timing for purchasing the stock.
According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
Thanks to a sound financial situation, the firm has significant leeway for investment.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The company has insufficient levels of profitability.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The company's "enterprise value to sales" ratio is among the highest in the world.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Analysts covering the stock have recently lowered their earnings forecast.
For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The underlying tendency is negative on the weekly chart below the resistance at 6.1 CAD